3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
2
Thyroid Neoplasms
1
Ras-mutated Metastatic Colorectal Cancer
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Histiocytosis
1
Gastrointestinal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Neuroendocrine
1
Carcinoma, Basal Cell
1
CRC
1
Brain Neoplasms
1
Advanced Gastric or EGJ Cancer
1
Interventions
Gemcitabine
31
Cisplatin
22
pembrolizumab
21
Magnetic Resonance Spectroscopy
18
Specimen Handling
16
durvalumab
11
Mitomycin
10
enfortumab vedotin
9
avelumab
9
Cystoscopy
9
Nivolumab
8
Fluorouracil
8
Carboplatin
8
Radiation
7
Cystectomy
7
atezolizumab
5
Transurethral Resection of Bladder
5
Radiotherapy
5
Mitozytrex
5
Immunoglobulin G
5
Docetaxel
5
Disulfides
5
Biopsy
5
tremelimumab
4
sacituzumab govitecan
4
erdafitinib
4
dehydroftorafur
4
Platinum
4
1,2-diaminocyclohexaneplatinum II citrate
4
disitamab vedotin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
IFL protocol
×
90 days
×
Clear all
No trials found.